The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential

被引:4
|
作者
Devan, Aswathy R. [1 ]
Nair, Bhagyalakshmi [1 ]
Pradeep, Govind K. [1 ]
Alexander, Roshini [1 ]
Vinod, Balachandran S. [2 ]
Nath, Lekshmi R. [1 ]
Calina, Daniela [3 ]
Sharifi-Rad, Javad [4 ,5 ]
机构
[1] Amrita Vishwa Vidyapeetham, Amrita Sch Pharm, Dept Pharmacognosy, AIMS Hlth Sci Campus,Ponekkara PO, Kochi 682041, Kerala, India
[2] Sree Narayana Coll, Dept Chem, Kollam 691001, Kerala, India
[3] Univ Med & Pharm Craiova, Dept Clin Pharm, Craiova 200349, Romania
[4] Univ Espiritu Santo, Samborondon 092301, Ecuador
[5] Korea Univ, Coll Med, Dept Med, Seoul 02841, South Korea
关键词
Apoptosis; Glypican-3; Hepatocellular carcinoma; Oncogenesis; Signal transduction; SULFATASE; 2; CELLS; MACROPHAGES; INHIBITOR; APOPTOSIS; PATHWAY; BIOLOGY; GROWTH; ERK;
D O I
10.1186/s40001-024-02073-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glypican-3 (GPC-3) is predominantly found in the placenta and fetal liver, with limited expression in adult tissues. Its re-expression in hepatocellular carcinoma (HCC) and secretion into the serum highlights its potential as a diagnostic marker. GPC-3 is involved in important cellular processes such as proliferation, metastasis, apoptosis, and epithelial-mesenchymal transition through various signaling pathways including Wnt, IGF, YAP, and Hedgehog. To review the structure, biosynthesis, and post-translational modifications of GPC-3, and to elucidate its signaling mechanisms and role as a pro-proliferative protein in HCC, emphasizing its diagnostic and therapeutic potential. A comprehensive literature review was conducted, focusing on the expression of GPC-3 in various tumors, with a special emphasis on HCC. The review synthesized findings from experimental studies and clinical trials, analyzing the overexpression of GPC-3 in HCC, its differentiation from other liver diseases, and its potential as a diagnostic and therapeutic target. GPC-3 overexpression in HCC is linked to aggressive tumor behavior and poor prognosis, including shorter overall and disease-free survival. Additionally, GPC-3 has emerged as a promising therapeutic target. Ongoing investigations, including immunotherapies such as monoclonal antibodies and CAR-T cell therapies, demonstrate potential in inhibiting tumor growth and improving clinical outcomes. The review details the multifaceted roles of GPC-3 in tumorigenesis, including its impact on tumor-associated macrophages, glucose metabolism, and epithelial-mesenchymal transition, all contributing to HCC progression. GPC-3's re-expression in HCC and its involvement in key tumorigenic processes underscore its value as a biomarker for early diagnosis and a target for therapeutic intervention. Further research is warranted to fully exploit GPC-3's diagnostic and therapeutic potential in HCC management.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
    Allegretta, Mark
    Filmus, Jorge
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (06) : 543 - 548
  • [2] Glypican-3 as a Potential Therapeutic Target for Hepatocellular Carcinoma Immunotherapy
    Trinh, Thu
    Liu, Chen
    FASEB JOURNAL, 2012, 26
  • [3] Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
    Filmus, Jorge
    Capurro, Mariana
    FEBS JOURNAL, 2013, 280 (10) : 2471 - 2476
  • [4] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (04) : 361 - 366
  • [5] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [6] Gene Expression of Hepatocellular Carcinoma Reveals Glypican-3 Role as Potential Biomarker
    Nastase, Anca
    Bacalbasa, Nicolae
    Ilie, Veronica
    Florea, Raluca
    Sorop, Andrei
    Tica, Valeria
    Paslaru, Liliana
    Iacob, Razvan
    Grigorie, Razvan
    Herlea, Vlad
    Dima, Simona
    Popescu, Irinel
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2014, 19 (05): : 9657 - 9665
  • [7] Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
    Zhou, Fubo
    Shang, Wenting
    Yu, Xiaoling
    Tian, Jie
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (02) : 741 - 767
  • [8] Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma
    Guo, Meng
    Zhang, Hailing
    Zheng, Jianming
    Liu, Yangfang
    JOURNAL OF CANCER, 2020, 11 (08): : 2008 - 2021
  • [9] Glypican-3 is a potential tumor marker for hepatocellular carcinoma.
    Kleeff, JH
    Zhu, ZW
    Wang, L
    Zimmermann, A
    Korc, M
    Friess, H
    Buchler, MW
    GASTROENTEROLOGY, 2000, 118 (04) : A261 - A261
  • [10] Immunohistochemical Pitfalls and the Importance of Glypican-3 in the Diagnosis of Scirrhous Hepatocellular Carcinoma
    Krings, G.
    Jain, D.
    Wu, T-T
    Yeh, M.
    Torbenson, M.
    Kakar, S.
    LABORATORY INVESTIGATION, 2011, 91 : 366A - 366A